Vista Pharmaceuticals (BOM:524711) Days Sales Outstanding : 416.02 (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Vista Pharmaceuticals Days Sales Outstanding?

Vista Pharmaceuticals's average Accounts Receivable for the three months ended in Mar. 2024 was ₹142.8 Mil. Vista Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was ₹31.3 Mil. Hence, Vista Pharmaceuticals's Days Sales Outstanding for the three months ended in Mar. 2024 was 416.02.

The historical rank and industry rank for Vista Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

BOM:524711' s Days Sales Outstanding Range Over the Past 10 Years
Min: 112.81 Med: 206.48 Max: 5842.77
Current: 435.4

During the past 13 years, Vista Pharmaceuticals's highest Days Sales Outstanding was 5842.77. The lowest was 112.81. And the median was 206.48.

BOM:524711's Days Sales Outstanding is ranked worse than
97.89% of 996 companies
in the Drug Manufacturers industry
Industry Median: 71.41 vs BOM:524711: 435.40

Vista Pharmaceuticals's Days Sales Outstanding declined from Mar. 2023 (1,022.86) to Mar. 2024 (416.02).

Vista Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Vista Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vista Pharmaceuticals Days Sales Outstanding Chart

Vista Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

149.36

1,794.10

5,842.77

3,948.36

452.93

Vista Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															1,022.86	518.25	296.74	604.07	416.02

Competitive Comparison of Vista Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Vista Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vista Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vista Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Vista Pharmaceuticals's Days Sales Outstanding falls into.

Vista Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Vista Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (112.509	+	142.814)	/	2 )	/	102.878	*	365
=	127.6615					/	102.878	*	365
=	452.93

Vista Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	142.814)	/	1 )	/	31.325	*	365 / 4
=	142.814					/	31.325	*	365 / 4
=	416.02

Vista Pharmaceuticals (BOM:524711) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Vista Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Vista Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Vista Pharmaceuticals (BOM:524711) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vista Pharmaceuticals Ltd (BOM:524711) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

Plot No. 104, Kakateeya Hills, Ravindra Co OP Society Guttala Begumpet, Hyderabad, TG, IND, 500033

Website

http://www.vistapharmaceuticals.com

Vista Pharmaceuticals Ltd is an Indian based company engaged in single operating segments that is the manufacturing of Pharmaceutical products. The company offers over the counter and prescription generic drug products such as tablets, capsules, and liquids covering various therapeutic categories. Some of the drugs in tablet dosage forms are Sulfamethoxazole and Trimethoprim, Bismuth Subgallate, Pyrantel Pamoate, Aspirin, Ibuprofen, Ranitidine HCl, and others. Nifedipine, Piroxicam, Indomethacin are the drugs offered by the company in a capsule dosage form. The business is carried out in India.

Vista Pharmaceuticals (BOM:524711) Headlines

No Headlines